Live Yum Brands Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow INVO Fertility, Inc.

Get SEC filing alerts via email and in your feed for INVO Fertility, Inc.

IVF

INVO Fertility, Inc.

About INVO Fertility, Inc.

INVO Fertility, Inc. is a healthcare services company specializing in assisted reproductive technology (ART). It operates fertility clinics, including INVO Centers utilizing its proprietary INVOcell device for in vivo fertilization, and acquires existing IVF clinics. The company focuses on expanding access to affordable fertility treatments, leveraging innovative devices and clinic networks to serve a large, underserved global market.
This description was generated via AI from an annual report. Updated 10 months ago.

Latest SEC Filings from INVO Fertility, Inc.

1
1
INVO Fertility, Inc. INVO Fertility Reports 23% Revenue Growth to $2.0 Million in Q1 2026

Via official filing (AI summary) | 29 days ago | 0 comments

2
1
INVO Fertility, Inc. INVO Fertility Reports $6.8 Million Revenue with Significant Net Loss and Strategic Acquisitions

Via official filing (AI summary) | about 2 months ago | 0 comments

3
1
INVO Fertility, Inc. INVO Fertility Reports 23% Revenue Growth but Increased Net Loss in Q3 2025

Via official filing (AI summary) | 8 months ago | 0 comments

4
1
INVO Fertility, Inc. INVO Fertility Reports Revenue Increase but Significant Net Loss for Quarter Ending June 30, 2025

Via official filing (AI summary) | 11 months ago | 0 comments

5
1
INVO Fertility, Inc. NAYA Biosciences Reports $17.4 Million Net Loss Amid Strategic Changes and Impairment Loss

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
INVO Fertility, Inc. INVO Fertility Reports 117% Revenue Growth to $6.5 Million for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
INVO Fertility, Inc. Naya Biosciences Reports 47% Revenue Growth, Net Loss in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments